Hemp lotion absorption under the microscope: new study launches

NCT ID NCT07603518

Recruiting now Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This early-stage study will test how a hemp-based CBD lotion with a small amount of THC is absorbed by the body. Twenty healthy adults will use the lotion in a clean, controlled environment. Researchers will measure cannabinoid levels in saliva, blood, and urine over time to understand how the body processes these compounds when applied to the skin.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hemp-based CBD topical lotion with low THC
What this could lead to: If successful, this study could help understand how topical cannabinoids enter the body, guiding future research on their effects.
What could go wrong: This is a very early Phase 1 study with only 20 participants, so results may not apply to the general population. It measures absorption, not health benefits or risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cannabis dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANNABIS

Contacts and locations

Locations

Behavioral Pharmacology Research Unit
RECRUITING

Baltimore, Maryland, 21224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.